Why Is Moderna Stock Trading Higher Today?

Moderna Inc MRNA stock surged on Tuesday after the company shared the AACR 2024 annual meeting poster presentation of mRNA-4157 (V940) individualized neoantigen therapy plus Merck & Co Inc’s MRK Keytruda (pembrolizumab) in advanced unresectable HPV-negative head and neck carcinoma. In a Phase 1…#modernainc #mrna4157 #v940 #merckcoincs #hpv #ifn #decreases #merck #keytruda
Source: Reuters: Health - Category: Consumer Health News Source Type: news